Drug intelligence / Profile preview

Onbax-R

Development stage
Unknown
Lead developer
Medicox Lifescience
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Onbax-R is a branded generic formulation of ondansetron, a potent and highly selective serotonin 5-HT3 receptor antagonist. Marketed by Medicox Lifescience, an Indian pharmaceutical company, it is primarily used as an antiemetic to prevent and treat nausea and vomiting associated with cancer chemotherapy, radiation therapy, and surgery. Ondansetron works by blocking 5-HT3 receptors located both peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone of the area postrema. By inhibiting these receptors, it prevents the initiation of the vomiting reflex. As an injectable formulation, Onbax-R provides a rapid onset of action and is particularly useful for patients who are unable to tolerate oral medications due to severe emesis.

Brand names
Onbax-R
Other names
ondansetron injection
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)HRH2 (Histamine H2 Receptor)

Beyond the preview

Go deeper on Onbax-R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onbax-R.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call